Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoer Xiaoji Zhike Oral Solution (also known as Xiao'er Xiaoji Zhike Oral Liquid) is a Traditional Chinese Medicine (TCM) oral solution developed and manufactured by Lunan Hope Pharmaceutical, a subsidiary of Lunan Pharmaceutical Group. It is formulated from ten herbal ingredients, including stir-baked hawthorn fruit (Crataegi Fructus), areca seed (Arecae Semen), immature orange fruit (Aurantii Fructus Immaturus), snakegourd fruit (Trichosanthis Fructus), honey-fried loquat leaf (Eriobotryae Folium), stir-baked radish seed (Raphani Semen), stir-baked lepidium seed (Lepidii Semen), platycodon root (Platycodonis Radix), weeping forsythia capsule (Forsythiae Fructus), and cicada slough (Cicadae Periostracum). The formulation is primarily indicated for the treatment of pediatric cough associated with food accumulation (indigestion) and phlegm-heat syndrome, presenting with symptoms such as cough (worse at night), throat phlegm, abdominal distension, and halitosis. It has also been evaluated in clinical trials as an adjunctive therapy combined with antibiotics (such as azithromycin) for Mycoplasma pneumoniae pneumonia in children.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiaoer Xiaoji Zhike Oral Solution.